Clinical remission by BMI in patients with severe eosinophilic asthma (SEA) over 1 year post benralizumab: real-world XALOC-2 programme

被引：0
|
作者：
Lommatzsch, Marek [1 ]
Rothe, Thomas [2 ]
Emmanuel, Benjamin [3 ]
Tran, Trung N. [3 ]
Menzies-Gow, Andrew [4 ]
Shavit, Anat [3 ]
Cohen, David [3 ]
Ho, Calvin N. [3 ]
Plate, Tanja [5 ]
Kayaniyil, Sheena [6 ]
Herreman, An [7 ]
Schuoler, Claudio [8 ]
Dupont, Lieven [9 ]
Penz, Erika [10 ]
机构：
[1] Univ Rostock, Rostock, Germany
[2] Cantonal Hosp GR Chur, Chur, Switzerland
[3] AstraZeneca, Gaithersburg, MD USA
[4] AstraZeneca, Cambridge, England
[5] AstraZeneca, Wedel, Germany
[6] AstraZeneca, Mississauga, ON, Canada
[7] AstraZeneca, Groot Bijgaarden, Belgium
[8] AstraZeneca, Baar, Switzerland
[9] Univ Hosp Leuven, Leuven, Belgium
[10] Univ Saskatchewan, Saskatoon, SK, Canada
来源：
EUROPEAN RESPIRATORY JOURNAL | 2024年 / 64卷
关键词：
D O I：
10.1183/13993003.congress-2024.PA3932
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: orbe II study
    Padilla-Galo, Alicia
    Carmona, Isabel Moya
    Ausin, Pilar
    Fernandez, Luis Carazo
    Garcia-Moguel, Ismael
    Velasco-Garrido, Jose Luis
    Andujar-Espinosa, Ruben
    Casas-Maldonado, Francisco
    Martinez-Moragon, Eva
    Rivera, Carlos Martinez
    Solsona, Elisabet Vera
    Lopez, Fernando Sanchez-Toril
    Alonso, Andrea Trisan
    Aparicio, Marina Blanco
    Valverde-Monge, Marcela
    Azcona, Borja Valencia
    Cervera, Marta Palop
    Nuevo, Javier
    Tena, Jesus Sanchez
    Resler, Gustavo
    Luzon, Elisa
    Naon, Alberto Levy
    RESPIRATORY RESEARCH, 2023, 24 (01)
  • [22] Super-responder analysis and real-world one year effectiveness of benralizumab in severe eosinophilic asthma
    Kavanagh, Joanne
    Roxas, Cris
    Green, Linda
    Fernandes, Mariana
    Thomson, Louise
    Payne, Victoria
    Hearn, Andrew
    Kent, Brian D.
    D'Ancona, Grainne
    Dhariwal, Jaideep
    Nanzer, Alexandra M. A.
    Jackson, David J.
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [23] Real-World Multicenter Experience with Mepolizumab and Benralizumab in the Treatment of Uncontrolled Severe Eosinophilic Asthma Over 12 Months
    Kayser, Moritz Z.
    Drick, Nora
    Milger, Katrin
    Fuge, Jan
    Kneidinger, Nikolaus
    Korn, Stephanie
    Buhl, Roland
    Behr, Juergen
    Welte, Tobias
    Suhling, Hendrik
    JOURNAL OF ASTHMA AND ALLERGY, 2021, 14 : 863 - 871
  • [24] Real-world evidence of benralizumab in patients with severe eosinophilic asthma and nasal polyps: initial results of the RANS study
    Le, T.
    Emmanuel, B.
    Kwiatek, J.
    Cohen, D.
    Kreindler, J.
    Tran, T.
    Katial, R.
    Daniel, S.
    Coulter, H.
    Cao, Y.
    Shih, V.
    Melcon, M. Gil
    Devouassoux, G.
    Klimek, L.
    Pelaia, G.
    ALLERGOLOGIE, 2022, 45 (08) : 614 - 615
  • [25] Real-world Evidence of Benralizumab in Patients With Severe Eosinophilic Asthma and Nasal Polyps: Initial Results of the RANS Study
    Le, T.
    Emmanuel, B.
    Kwiatek, J.
    Tran, T. N.
    Cohen, D.
    Kreindler, J. L.
    Katial, R.
    Daniel, S.
    Cao, Y.
    Shih, V.
    Gil Melcon, M.
    Devouassoux, G.
    Pelaia, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [26] Clinical remission (CR) in a real-world study to evaluate mepolizumab effectiveness in treating severe eosinophilic asthma (SEA) in Taiwan (REMIT)
    Xu, Xiaomeng
    Zhang, Shiyuan
    Rojas, Aldo Navarro
    Perng, Diahn-Warng
    Cheng, Shih-Lung
    Alfonso, Rafael
    Milea, Dominique
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [27] LONG-TERM REAL-WORLD EFFECTIVENESS OF BENRALIZUMAB IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA: RESULTS FROM THE ZEPHYR 2 STUDY
    Carstens, Donna D.
    Genofre, Eduardo H.
    Young, Joshua A.
    Yang, Danni
    Mu, Fan
    Cook, Erin E.
    Betts, Keith A.
    Chung, Yen
    CHEST, 2022, 162 (04) : 7A - 7A
  • [28] Mepolizumab Treatment Leads to Clinical Remission in Patients with Severe Eosinophilic Asthma: Results from the Real-World REDES Study
    Domingo Ribas, C.
    Pavord, I.
    Price, R. G.
    Howarth, P.
    Oppenheimer, J.
    Heaney, L.
    Nagase, H.
    Pizzichini, E.
    Banas Conejero, D.
    Gardiner, F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [29] Clinical Effectiveness of Benralizumab Is Independent of Baseline FeNO in Severe Eosinophilic Asthma: A Retrospective Real-World Observation Study in Five UK Severe Asthma Centers
    Jackson, D. J.
    Burhan, H.
    Menzies-Gow, A.
    Pfeffer, P. E.
    Nanzer, A.
    Gil, E. Garcia
    Morris, T.
    Tran, T. N.
    Hirsch, I
    Dube, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [30] Early response and remission with benralizumab in patients with severe asthma and chronic rhinosinusitis with nasal polyposis ( CRSwNP) in the prospective real-world imPROve Asthma study
    Korn, S.
    Watz, H.
    Emmanuel, B.
    Plate, T.
    Saathoff, M.
    Shavit, A.
    Grund, T.
    Lommatzsch, M.
    PNEUMOLOGIE, 2023, 77 : S76 - S76
12345